ALIMP Share Price Performance
Recent ALIMP News & Updates
No updates
Implanet S.A. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Sep 16, 2025
- Earnings per share (EPS)
- -0.042
- Gross Margin
- 43.58%
- Net Profit Margin
- -55.45%
- Debt/Equity Ratio
- 718.0%
Implanet S.A. Competitors
About ALIMP
- Founded
- 2006
- Employees
- 46
- CEO
- WebsiteView website
Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martillac, France.
French Market Performance
- 7 Days: -3.9%
- 3 Months: -3.1%
- 1 Year: 2.8%
- Year to Date: 0.7%
Over the last 7 days, the market has dropped 3.9%, driven by a loss of 7.9% in the Consumer Discretionary sector. Overall the market has been flat in the last year. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading